The heterogeneous disease course of COVID-19 is unpredictable, ranging from mild self-
limiting symptoms to cytokine storms, acute respiratory distress syndrome (ARDS), multi …

The number of COVID-19 patients is dramatically increasing worldwide. Treatment in
intensive care units (ICU) has become a major challenge; therefore, early recognition of …

Background To date, several clinical laboratory parameters associated with Coronavirus
disease 2019 (COVID-19) severity have been reported. However, these parameters have …

Background COVID-19 comprises several severity stages ranging from oligosymptomatic
disease to multi-organ failure and fatal outcomes. The mechanisms why COVID-19 is a mild …

Abstract Background Coronavirus disease 2019 (COVID-19) emerged first in December
2019 in Wuhan, China and quickly spread throughout the world. Clinical and laboratory data …

Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …

Objective To describe the laboratory parameters and biomarkers of the cytokine storm
syndrome associated with severe and fatal COVID-19 cases. Methods A search with …

Background Markedly elevated levels of proinflammatory cytokines and defective type-I
interferon responses were reported in patients with coronavirus disease 2019 (COVID-19) …